Research programme: AMPK activators - Abbott Laboratories
Latest Information Update: 08 Feb 2013
At a glance
- Originator Abbott Laboratories
- Class Small molecules
- Mechanism of Action AMP activated protein kinase stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Metabolic disorders